A Controlled Multi-Arm Ph1 Study Evaluating the Safety and Feasibility of TCR Engineered Donor TCells Targeting HA1 (TSC-100) or HA2 (TSC-101) in HLA-A0201 Positive Patients Undergoing Haploidentical Allogeneic Stem Cell Transplantation Read more
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel Read more
Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release Read more
Post-Transplant Chimerism Patterns in Patients with Myelodysplastic Syndromes and Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation at the John Theurer Cancer Center Read more
Dynamic Changes in Pre- and Post-Transplant NGS MRD Status For Prediction of the Allogeneic Stem Cell Transplant Outcome in Patients with AML Read more
Multicenter Study to Evaluate Incidence and Outcomes of Cardiovascular Events in Adult Reduced Intensity Conditioning Allogeneic Hematopoietic Cellular Transplantation Recipients Receiving Post-Transplantation Cyclophosphamide Read more
